Veradermics, Incorporated (MANE)

NYSE:MANE

US Market

MANE

Veradermics, Incorporated

RESEARCH TOOLSreports

Want to see MANE full AI Analyst Report?

Veradermics, Incorporated (MANE) Ownership - Who Owns Veradermics, Incorporated?

23 Followers

Veradermics, Incorporated (MANE) Ownership Overview

20.76% Insiders

<0.01% Other Institutional Investors

2.28% ETFs

76.96% Public Companies and

Individual Investors

The ownership structure of Veradermics, Incorporated (MANE) stock is a mix of institutional, retail, and individual investors. , 20.76% is owned by Insiders, and 76.96% is owned by Public Companies and Individual Investors.

The ownership structure of Veradermics, Incorporated (MANE) stock is a mix of institutional, retail, and individual investors. Approximately 2.28% of the company’s stock is owned by Institutional Investors, 20.76% is owned by Insiders, and 76.96% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Feb 09, 2026	Suvretta Capital Management, Llc	xxxxxxxxxxxxx	$10542478
Feb 05, 2026	Longitude Capital Partners V, Llc	xxxxxxxxxxxxx	$18275000
Feb 05, 2026	Vlad Coric	xxxxxxxxxxxxx	$1999982
Feb 05, 2026	Patrick Enright	xxxxxxxxxxxxx	$18275000

Show More Insider Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	2,202,006	Insider	5.90%	234,623,739
	2,053,474	Insider	5.50%	218,797,655
	2,053,474	Insider	5.50%	218,797,655
	687,942	Institution	1.84%	73,300,220
	520,453	Insider	1.39%	55,454,267
	449,337	Insider	1.20%	47,876,857
	234,907	Insider	0.63%	25,029,341
	234,872	Insider	0.63%	25,025,612
	89,431	Institution	0.24%	9,528,873
	27,629	Institution	0.07%	2,943,870

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	504,706	Institution	1.35%	31,872,184
Vanguard Extended Market ETF	178,699	Institution	0.48%	11,284,842
Schwab U.S. Small-Cap ETF	78,791	Institution	0.21%	8,123,352
F/M Emerald Life Sciences Innovation ETF	27,629	Institution	0.07%	2,848,550
iShares Core S&P Total U.S. Stock Market ETF	22,882	Institution	0.06%	2,359,134
First Trust US Equity Opportunities ETF	19,734	Institution	0.05%	2,102,658
Schwab U.S. Broad Market ETF	10,640	Institution	0.03%	1,096,984
Vanguard Russell 2000 ETF	3,959	Institution	0.01%	250,011
Innovator IBD Breakout Opportunities ETF	3,514	Institution	<0.01%	351,751
Vanguard Russell 2000 Growth ETF	385	Institution	<0.01%	24,313

FAQ

Who Owns Veradermics, Incorporated (MANE)?

According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 20.76% is held by insiders, and 76.96% is held by retail investors.

What percentage of Veradermics, Incorporated (MANE) stock is held by institutional investors?

According to the latest TipRanks data, approximately <0.01% of Veradermics, Incorporated (MANE) stock is held by institutional investors.

What percentage of Veradermics, Incorporated (MANE) stock is held by retail investors?

According to the latest TipRanks data, approximately 76.96% of Veradermics, Incorporated (MANE) stock is held by retail investors.

Who owns the most shares of Veradermics, Incorporated (MANE)?

John Childs owns the most shares of Veradermics, Incorporated (MANE).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.